Home
Scholarly Works
Competing risks of death in NCIC CTG MA.27...
Conference

Competing risks of death in NCIC CTG MA.27 adjuvant exemestane versus anastrozole.

Authors

Chapman J-AW; Shepherd LE; Ingle JN; Muss HB; Pritchard KI; Gelmon KA; Whelan TJ; Elliott C; Goss PE

Volume

31

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

May 20, 2013

Name of conference

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference place

IL, Chicago

Conference start date

May 31, 2013

Conference end date

June 4, 2013

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team